% | $
Quotes you view appear here for quick access.

Spherix Incorporated Message Board

  • financesajeed financesajeed Mar 10, 2013 11:35 AM Flag

    SPEX: Expanding international Market

    Spherix Incorporated (SPEX) is a well-known scientific research company with long exposure as well as presence in the market. The company has been expanding segments not only in domestic market but also in foreign markets. Today we may discuss the company’s recent business dealing with Fulllife Health care Pvt. Ltd, an innovation driven company focused on bringing healthcare solutions to India. Before gonin detail, le t us know more SPEX. The company has been developing biopharmaceutical products and also has been providing technical and regulatory consulting services to food, consumer products and pharmaceuticals companies. SPEX has been operating basically in two segments; first segment is Biospherics Incorporated (Biospherics) which is biotechnology research and development business and another segment is Health science, which is technical and regulatory consulting business. The company has been utilizing its subsidiary companies to ensure customer supply of customer demanded products and services. Agreement with Fulllife Health care Pvt. Ltd. is aimed basically to facilitate to supply and license agreement for the use of D-tagatose nutraceutical products in India. As part of its penetration to international market, the above dealing may bring good operating result for the company. As per press release from SPEX,” under the terms of the agreement, Spherix has granted Fullife an exclusive, royalty-bearing license in India for use of Spherix's clinical data and proprietary know-how to support marketing and dosing of the D-tagatose that Spherix will also be supplying. The D-tagatose will be used in food or cosmetic products that may provide health benefits in return for a fixed royalty on gross sales. Spherix will provide bulk D-Tagatose to Fullife and Fullife will be responsible for all testing and development of products containing D-Tagatose for sale in India. According to SPEX ex CEO Dr. Claire Kruger, "we are delighted to enter into this supply and license agr

1.33+0.03(+2.31%)2:07 PMEDT